Andere talen Notable Labs, Ltd.

Aandelen

NTBL

IL0012002452

slotkoers Nasdaq Andere beurzen 00:00:00 27-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,671 ^USD	+5,62%		-3,29%	-64,50%

16/05	NOTABLE LABS, LTD. : Chardan Research herhaalt koopadvies	ZM
15/05	Notable Labs, Ltd. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Notable Labs, Ltd.(NasdaqCM:NTBL) added to S&P TMI Index	24/06
Notable Labs : Corporate Presentation	19/06
Notable Labs : Corporate Presentation	12/06
Notable Labs : Corporate Presentation	30/05
Il coefficiente di Nakamoto: l'arma definitiva della decentralizzazione?	29/05
Notable Labs, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024	09/05
VASR BIOG : Notable Corporate Presentation	06/05
Notable Labs Reports 2023 Financial Results and Provides a Business Update	15/04
Notable Labs Reports 2023 Financial Results and Provides a Business Update	12/04
VASR BIOG : AACR 2024 VOLA Poster	09/04
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024	09/04
Notable Labs, Ltd. Presents the Design Plan for the Ppmp-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024	09/04
VASR BIOG : AACR 2024 Poster	08/04
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform	08/04
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay At AACR 2024 Expands the Potential of the Platform	08/04
OPINIONES DE LOS ANALISTAS DEL DÍA : Stellantis, Aena, Richemont, Adyen, Fraport, BBVA, Aperam, Enagás, Sacyr, BE Semi...	02/04
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform	05/03
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment	22/02
Notable Labs, Ltd. Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment	22/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Notable Labs, Ltd.

Aandelen

NTBL

IL0012002452

Andere talen

Filters